News

Dutch is leading the College of Medicine’s COVID-19 Unified Research Experts (CURE) Alliance team, which brings together faculty expertise from multiple disciplines across the university to focus on advising COVID-19 patient care and clinical trials based on emerging research.

CCTS is partnering with NCATS, the National Center for Data to Health, and around 60 other clinical institutions affiliated with the NCATS Clinical and Translational Science Awards Program to leverage big data in the fight against COVID-19.

The new potential treatment has been added to the University of Kentucky’s innovative clinical trial for experimental COVID-19 therapies, which was launched by leaders from UK’s Markey Cancer Center, College of Medicine and College of Pharmacy in May.

UK announced a research collaboration with Atomwise, an industry leader in using artificial intelligence (AI) for small molecule discovery, to explore potential COVID-19 therapies.

UK College of Medicine researchers are using the special antibodies made by alpacas, called nanobodies, to help understand the novel coronavirus and potentially develop a treatment that could protect people from being infected. 

Known as Serologic Testing to Accelerate Recovery and Transition (START), the study focuses on antibody testing to begin understanding how many people in the region may have already contracted and recovered from COVID-19.

UK researchers across many disciplines are addressing COVID-19’s medical challenges and beyond — including developing new PPE materials, designing testing and diagnostic equipment, and examining the wider societal, economic and legal implications of the pandemic.

The study seeks to answer how sectors of local and regional food systems are responding to COVID-19, what successful adaptations have been implemented, what obstacles the various arms of local food systems have encountered and the economic and value-chain impacts.

Researchers at UK are exploring the use of an antiseptic nasal spray and gargle to prevent transmission and infection of the virus among healthcare workers and non-COVID patients.

A new pilot funding program for multidisciplinary COVID-19 research at the University of Kentucky has launched in record time and funded 12 pilot projects in as many weeks.